Sotera Health (NASDAQ:SHC) Short Interest Update

by · The Markets Daily

Sotera Health (NASDAQ:SHC – Get Free Report) was the recipient of a large decline in short interest during the month of December. As of December 15th, there was short interest totalling 6,610,000 shares, a decline of 18.7% from the November 30th total of 8,130,000 shares. Currently, 4.3% of the company’s stock are short sold. Based on an average daily volume of 1,260,000 shares, the days-to-cover ratio is currently 5.2 days.

Institutional Investors Weigh In On Sotera Health

Hedge funds and other institutional investors have recently modified their holdings of the company. Retirement Systems of Alabama increased its position in Sotera Health by 20.8% during the third quarter. Retirement Systems of Alabama now owns 185,779 shares of the company’s stock worth $3,103,000 after acquiring an additional 32,051 shares during the period. Sanctuary Advisors LLC increased its holdings in shares of Sotera Health by 154.4% during the third quarter. Sanctuary Advisors LLC now owns 29,088 shares of the company’s stock worth $486,000 after purchasing an additional 17,652 shares during the period. Neo Ivy Capital Management acquired a new stake in shares of Sotera Health in the third quarter valued at approximately $720,000. Geode Capital Management LLC grew its position in Sotera Health by 19.4% during the third quarter. Geode Capital Management LLC now owns 2,755,391 shares of the company’s stock worth $46,026,000 after buying an additional 447,186 shares in the last quarter. Finally, Barclays PLC raised its holdings in Sotera Health by 169.8% in the 3rd quarter. Barclays PLC now owns 473,597 shares of the company’s stock valued at $7,909,000 after acquiring an additional 298,085 shares in the last quarter. Institutional investors and hedge funds own 91.03% of the company’s stock.

Sotera Health Stock Performance

Shares of NASDAQ SHC traded down $0.12 during mid-day trading on Monday, reaching $13.36. 873,018 shares of the company were exchanged, compared to its average volume of 1,331,054. The stock has a market capitalization of $3.78 billion, a P/E ratio of 53.44 and a beta of 1.96. The company has a quick ratio of 2.61, a current ratio of 2.88 and a debt-to-equity ratio of 4.91. The company’s 50-day simple moving average is $14.17 and its 200-day simple moving average is $14.29. Sotera Health has a twelve month low of $10.71 and a twelve month high of $17.44.

Sotera Health (NASDAQ:SHC – Get Free Report) last issued its quarterly earnings data on Tuesday, November 5th. The company reported $0.17 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.01). The firm had revenue of $285.47 million for the quarter, compared to the consensus estimate of $278.64 million. Sotera Health had a return on equity of 42.27% and a net margin of 6.31%. The company’s revenue was up 8.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.18 EPS. As a group, research analysts predict that Sotera Health will post 0.61 earnings per share for the current year.

Analyst Ratings Changes

SHC has been the topic of several analyst reports. Citigroup upped their price target on shares of Sotera Health from $18.00 to $20.00 and gave the stock a “buy” rating in a research report on Wednesday, November 6th. Royal Bank of Canada reiterated an “outperform” rating and issued a $17.00 target price on shares of Sotera Health in a research note on Thursday, November 21st. Finally, The Goldman Sachs Group initiated coverage on Sotera Health in a research report on Friday, December 6th. They set a “neutral” rating and a $14.00 price target on the stock. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Sotera Health currently has an average rating of “Moderate Buy” and a consensus price target of $16.08.

Read Our Latest Stock Analysis on SHC

About Sotera Health

(Get Free Report)

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.

Recommended Stories